Table 6. Primary diagnoses resulting in the referral for anti-hepatitis C virus tests, Poland, 2004–2014 (n = 36,356 patients).
| LBID012_Diagnosis | Number of patients tested | Number of patients with positive results | Proportion of positive patients |
Proportion of positive
women |
Proportion of positive men | Proportion positive in column | Proportion of diagnosed patients |
|---|---|---|---|---|---|---|---|
| Pregnancy and pregnancy related conditions | 16,130 | 122 | 0.8% | 0.8% | NA | 25.4% | 44.4% |
| Preventive consultations of generally healthy personsa | 6,456 | 75 | 1.2% | 0.7% | 1.0% | 15.6% | 17.8% |
| Various symptoms and signs | 5,151 | 108 | 2.1% | 1.0% | 2.1% | 22.5% | 14.2% |
| Hypertransaminasaemiab | 1,093 | 25 | 3.7% | 1.1% | 1.7% | 5.2% | 3.0% |
| Fatty liver disease | 1,115 | 23 | 3.4% | 0.8% | 1.7% | 4.8% | 3.1% |
| Othersc | 6,411 | 127 | 1.5% | 0.9% | 2.6% | 26.5% | 17.6% |
| Total | 36,356 | 480 | 1.1% | 0.8% | 1.9% | 100.00% | 100.0% |
NA: not applicable.
a Spontaneous or obligatory health check-ups.
b Excluding people with elevated transaminase level as a reason of additional anti-HCV test.
c Most often before surgical procedures.